跳至主要内容
临床试验/JPRN-UMIN000048583
JPRN-UMIN000048583尚未招募未知

Follow-up of the efficacy of topical CG428 for chemotherapy-induced nail damage in breast cancer patients undergoing adjuvant chemotherapy. - Follow-up of the efficacy of CG428 on nail disorders in breast cancer patients undergoing chemotherapy

agasaki Harbor Medical Center0 个研究点目标入组 40 人开始时间: 2022年8月12日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. Patients undergoing chemotherapy treatment for other diseases 2. Patients with pre-treatment nail symptoms 3. Patients receiving any kind of treatment for nail symptoms 4. Patients with a history of hypersensitivity to ingredients of topical agents (e.g. ethanol), cosmetics, hair growth products, etc. 5. Other patients deemed inappropriate as research subjects by the investigators

研究者

发起方
agasaki Harbor Medical Center

相似试验